Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

It’s a bad day when a doctor says you have cancer. It’s a worse day when he says it’s stage prostate cancer with a metastatic ...

Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal ...

Surviving cancer wasn’t the end of my story; it was the start of redefining life, finding purpose and offering hope to those ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer ...

Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

I can still clearly remember people’s reactions after I finished chemo for the first time in 2014, a few months after my ...

FDA approves updated labeling for Talzenna plus Xtandi in men with HRR gene-mutated metastatic prostate cancer, showing a ...

Dr. Rita Mukhtar and Dr. Joshua K. Sabari discuss the role of ctDNA to guide surgical decision-making after neoadjuvant chemo in breast cancer treatment.

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...